Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]

View source ↗

Summary

An extension study (Phase 2) evaluating long-term safety and tolerability of UTTR1147A in moderate-to-severe Ulcerative Colitis or Crohn's Disease has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• UTTR1147A (null)

Snippet

Sponsor: Genentech, Inc. | Conditions: Ulcerative Colitis, Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-09-29